NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,160 filers reported holding NOVARTIS A G in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,058 | +17.5% | 354 | +16.4% | 0.01% | +25.0% |
| Q2 2023 | $30,677 | +27.3% | 304 | +16.0% | 0.01% | +14.3% |
| Q1 2023 | $24,104 | +1.4% | 262 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $23,769 | +18.8% | 262 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $20,000 | -9.1% | 262 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $22,000 | -4.3% | 262 | 0.0% | 0.01% | +16.7% |
| Q1 2022 | $23,000 | 0.0% | 262 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $23,000 | -43.9% | 262 | -45.9% | 0.01% | -50.0% |
| Q1 2021 | $41,000 | +24.2% | 484 | +29.1% | 0.01% | +9.1% |
| Q3 2020 | $33,000 | +371.4% | 375 | +400.0% | 0.01% | +450.0% |
| Q3 2019 | $7,000 | -87.7% | 75 | -88.7% | 0.00% | -92.0% |
| Q3 2017 | $57,000 | +850.0% | 661 | +781.3% | 0.02% | +733.3% |
| Q2 2017 | $6,000 | – | 75 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |